Hepatocellular carcinoma secondary prevention

Jump to navigation Jump to search

Hepatocellular carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes of Hepatocellular carcinoma

Differentiating Hepatocellular carcinoma from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

Diagnostic study of choice

History and symptoms

Physical Examination

Lab Tests

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hepatocellular carcinoma secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatocellular carcinoma secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatocellular carcinoma secondary prevention

CDC on Hepatocellular carcinoma secondary prevention

Hepatocellular carcinoma secondary prevention in the news

Blogs on Hepatocellular carcinoma secondary prevention

Directions to Hospitals Treating Hepatocellular carcinoma

Risk calculators and risk factors for Hepatocellular carcinoma secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]

Overview

Secondary prevention strategies following hepatocellular carcinoma include retinoids, Intra-arterial iodine-131-lipiodol embolization, and adoptive adjuvant immunotherapy.

Secondary Prevention

Secondary prevention strategies following hepatocellular carcinoma include retinoids, Intra-arterial iodine-131-lipiodol embolization, and adoptive adjuvant immunotherapy.[1]

References

  1. Colombo M, Donato MF (2005). "Prevention of hepatocellular carcinoma". Semin Liver Dis. 25 (2): 155–61. doi:10.1055/s-2005-871195. PMID 15918144.


Template:WikiDoc Sources